A Novel Technique for Endoscopic Transaxillary Thyroidectomy Comparison
A Novel Technique for Endoscopic Transaxillary Thyroidectomy: a Preliminary Report and Comparison With the Open Procedure
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Xi'an, China, 710004
- Department of General Surgery , Second Affiliated Hospita l, Xi'an Jiaotong Universi ty School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- The patients with benign or malignant thyroid disease require lobe thyroidectomy;
- The patient had cosmetic requirements and agreed with transaxillary thyroidectomy;
- Benign lesions with the largest diameter ≤5 cm;
- Differentiated thyroid cancer(DTC) meets the following conditions at the same time: ①The maximum diameter of the primary lesion is <2.5 cm; ②There is no extraglandular invasion or only minimal external invasion of the anterior thyroid capsule or minor invasion of the sternum thyroid muscle;
Exclusion Criteria:
- the patients had poor compliance and could not be reexamined regularly;
- There was a history of neck or thyroid surgery;
- The patients require total thyroidectomy or lateral neck dissection.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
endoscopic group
the patients who underwent endoscopic transaxillary thyroidectomy
|
the patients who underwent endoscopic transaxillary thyroidectomy
|
|
open group
the patients who underwent open thyroidectomy
|
the patients who underwent endoscopic transaxillary thyroidectomy
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
operation time (OT)
Time Frame: during the operation
|
The time will be reported as minutes.
|
during the operation
|
|
bleeding
Time Frame: during the operation
|
intraoperatively bleeding volume.
The intraoperative blood lose volume will be reported as ml.
|
during the operation
|
|
complications
Time Frame: 6 moths after oepration
|
any complications after operation
|
6 moths after oepration
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
hospital stay
Time Frame: 1 week
|
How many days will the patients stay in the hospital.
The index will be reported as days.
|
1 week
|
|
drainage days.
Time Frame: 1 week
|
This index will record how many days does the drainage tube keep in the paitients.
It will reported as days.
|
1 week
|
|
drainage volume
Time Frame: 1 week
|
This index will record the total volume from drainage tube after operation.
It will reported as ml.
|
1 week
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Yang Liu, Xi'an Jiaotong University Second Affiliated Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 202303
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.